FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

35096411000001107: Seractil 300mg tablets (Gebro Pharma GmbH) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 21-Feb 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
106303801000001110 Seractil 300mg tablets (Gebro Pharma GmbH) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
106303901000001116 Seractil 300mg tablets (Gebro Pharma GmbH) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Seractil 300mg tablets (Gebro Pharma GmbH) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Seractil 300mg tablets (Gebro Pharma GmbH) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Seractil 300mg tablets (Gebro Pharma GmbH) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Seractil 300mg tablets (Gebro Pharma GmbH) Is a Product containing precisely dexibuprofen 300 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Seractil 300mg tablets (Gebro Pharma GmbH) Has active ingredient Dexibuprofen false Inferred relationship Existential restriction modifier 1
Seractil 300mg tablets (Gebro Pharma GmbH) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Seractil 300mg tablets (Gebro Pharma GmbH) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Seractil 300mg tablets (Gebro Pharma GmbH) Has basis of strength substance Dexibuprofen true Inferred relationship Existential restriction modifier 1
Seractil 300mg tablets (Gebro Pharma GmbH) Has presentation strength numerator value 300 false Inferred relationship Existential restriction modifier 1
Seractil 300mg tablets (Gebro Pharma GmbH) Has presentation strength numerator unit milligram true Inferred relationship Existential restriction modifier 1
Seractil 300mg tablets (Gebro Pharma GmbH) Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 1
Seractil 300mg tablets (Gebro Pharma GmbH) Has presentation strength denominator unit Tablet true Inferred relationship Existential restriction modifier 1
Seractil 300mg tablets (Gebro Pharma GmbH) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Seractil 300mg tablets (Gebro Pharma GmbH) Has specific active ingredient Dexibuprofen true Inferred relationship Existential restriction modifier
Seractil 300mg tablets (Gebro Pharma GmbH) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Seractil 300mg tablets (Gebro Pharma GmbH) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Seractil 300mg tablets (Gebro Pharma GmbH) Is a Seractil true Inferred relationship Existential restriction modifier
Seractil 300mg tablets (Gebro Pharma GmbH) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Seractil 300mg tablets (Gebro Pharma GmbH) VMP non-availability indicator Re-introduced false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Seractil 300mg tablets (Gebro Pharma GmbH) 60 tablet Has AMP True Seractil 300mg tablets (Gebro Pharma GmbH) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start